CLOs on the Move

EcoNugenics

www.econugenics.com

 
EcoNugenics® was founded in 1995 by Dr. Isaac Eliaz, M.D., M.S., L.Ac. - a pioneer and expert in the field of integrative medicine, and a highly regarded clinical practitioner, formulator, researcher and author. Dr. Eliaz leads our research activities in natural, integrative approaches to cellular, immune, metabolic, digestive, and cardiovascular health, as well as detoxification.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Gladstone Institutes

Gladstone`s mission is to drive a new era of discovery in disease-oriented science and to mentor tomorrow`s leaders in an inspiring and diverse environment.

RetireeFirst

Established in 2005 and currently servicing over 250 clients, RetireeFirst (formerly LaborFirst) is the premier retiree benefit management solutions and advocacy service provider, proven to enhance the experience and outcomes for group plan sponsors, employers, and their retirees. Our sole focus on retiree benefits means our solutions and services, combined with our people-centric approach, deliver immediate savings, significantly reduce administrative burden, and help preserve the benefits retirees deserve. Our unparalleled retiree advocacy service connects members to programs that help improve their health and wellness, resulting in happier and more engaged members. We go above and beyond for our clients, and our Advocates give retirees a guiding hand to navigate their entire healthcare and benefits journey—ensuring peace of mind.

Insilicomed

Insilicomed, Inc. is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Altos Solutions

Altos Solutions is a Los Altos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

T1D Exchange

T1D Exchange, a nonprofit organization, is a dynamic, multi-purpose, real-world patient data platform designed to accelerate all aspects of drug and device development. T1D Exchange has established a unique model to speed better treatments, therapies and research for type 1 diabetes (T1D). The Exchange consists of an integrated Clinic Network of 65+ clinics across the U.S., a Clinic Registry of 26,000 well-characterized patients, a Biorepository, and Glu, an online community with mobile capabilities for people touched by type 1 diabetes. The T1D Exchange fosters faster and more fluid information transfer and sharing among diabetes patients, physicians, researchers, and pharma, medical device, education, and outreach organizations.